Whiteman D C, Sadeghi S, Pandeya N, Smithers B M, Gotley D C, Bain C J, Webb P M, Green A C
Division of Population Studies and Human Genetics, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland 4029, Australia.
Gut. 2008 Feb;57(2):173-80. doi: 10.1136/gut.2007.131375. Epub 2007 Oct 11.
To measure the relative risks of adenocarcinomas of the oesophagus and gastro-oesophageal junction associated with measures of obesity, and their interactions with age, sex, gastro-oesophageal reflux symptoms and smoking.
Population-based case-control study in Australia.
Patients with adenocarcinomas of the oesophagus (n = 367) or gastro-oesophageal junction (n = 426) were compared with control participants (n = 1580) sampled from a population register.
Relative risk of adenocarcinoma of the oesophagus or gastro-oesophageal junction.
Risks of oesophageal adenocarcinoma increased monotonically with body mass index (BMI) (p(trend) <0.001). Highest risks were seen for BMI >or=40 kg/m2 (odds ratio (OR) = 6.1, 95% CI 2.7 to 13.6) compared with "healthy" BMI (18.5-24.9 kg/m2). Adjustment for gastro-oesophageal reflux and other factors modestly attenuated risks. Risks associated with obesity were substantially higher among men (OR = 2.6, 95% CI 1.8 to 3.9) than women (OR = 1.4, 95% CI 0.5 to 3.5), and among those aged <50 years (OR = 7.5, 95% CI 1.7 to 33.0) than those aged >or=50 years (OR = 2.2, 95% CI 1.5 to 3.1). Obese people with frequent symptoms of gastro-oesophageal reflux had significantly higher risks (OR = 16.5, 95% CI 8.9 to 30.6) than people with obesity but no reflux (OR = 2.2, 95% CI 1.1 to 4.3) or reflux but no obesity (OR = 5.6, 95% 2.8 to 11.3), consistent with a synergistic interaction between these factors. Similar associations, but of smaller magnitude, were seen for gastro-oesophageal junction adenocarcinomas.
Obesity increases the risk of oesophageal adenocarcinoma independently of other factors, particularly among men. From a clinical perspective, these data suggest that patients with obesity and frequent symptoms of gastro-oesophageal reflux are at especially increased risk of adenocarcinoma.
测量与肥胖指标相关的食管腺癌和胃食管交界腺癌的相对风险,以及它们与年龄、性别、胃食管反流症状和吸烟之间的相互作用。
澳大利亚基于人群的病例对照研究。
将食管腺癌患者(n = 367)或胃食管交界腺癌患者(n = 426)与从人口登记册中抽取的对照参与者(n = 1580)进行比较。
食管或胃食管交界腺癌的相对风险。
食管腺癌风险随体重指数(BMI)单调增加(趋势p<0.001)。与“健康”BMI(18.5 - 24.9 kg/m²)相比,BMI≥40 kg/m²时风险最高(优势比(OR)= 6.1,95%可信区间2.7至13.6)。对胃食管反流和其他因素进行调整后,风险略有降低。肥胖相关风险在男性(OR = 2.6,95%可信区间1.8至3.9)中显著高于女性(OR = 1.4,95%可信区间0.5至3.5),在年龄<50岁者(OR = 7.5,95%可信区间1.7至33.0)中高于年龄≥50岁者(OR = 2.2,95%可信区间1.5至3.1)。有频繁胃食管反流症状的肥胖者风险显著高于无反流的肥胖者(OR = 2.2,95%可信区间1.1至4.3)或有反流但不肥胖者(OR = 5.6,95%可信区间2.8至11.3),这与这些因素之间的协同相互作用一致。胃食管交界腺癌也有类似关联,但程度较小。
肥胖独立于其他因素增加食管腺癌风险,尤其是在男性中。从临床角度看,这些数据表明肥胖且有频繁胃食管反流症状的患者患腺癌风险尤其增加。